ITGB3 has been demonstrated to be modulated by miR‐95 to regulate the proliferation, migration and invasion of non‐small‐cell lung cancer.10 In addition, abnormal PASMC proliferation is a pathological feature of PAH,11 although there has been no specific research investigating the role of ITGB3 in PAH. This evidence concerns the gene ITGB3 and pulmonary arterial hypertension.